Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

about

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

Item

http://www.wikidata.org/entity/Q47877598

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

@en

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

@nl

type

Item

label

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

@en

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

@nl

prefLabel

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

@en

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

@nl

P1476

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma.

@en

P2093

Leping Li

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Li

http://www.w3.org/2001/XMLSchema#string

P2860

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

The role of microRNA genes in papillary thyroid carcinoma

mTOR signaling in growth control and disease

miR-221 overexpression contributes to liver tumorigenesis

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer

P304

527-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CMR.0000000000000388

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David M Umbach

P577

2017-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28858076

http://www.w3.org/2001/XMLSchema#string

P932

5669042

http://www.w3.org/2001/XMLSchema#string